Sector ratings Shionogi & Co., Ltd.

Equities

Market Closed - Japan Exchange Other stock markets 07:30:00 08/05/2026 BST			5-day change	1st Jan Change
3,177.00 ^JPY	+0.83%		+1.57%	+11.83%

04-27	Shionogi to Absorb Torii Pharmaceutical in April 2027 Merger	MT
04-15	StemRIM Inc. Announces Completion of Patient Enrollment in Phase 1/2 InvestigatorInitiated Clinical Trial of Redasemtide for Patients with Ischemic Cardiomyopathy	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
SHIONOGI & CO., LTD.	17.26B		AA
ELI LILLY AND COMPANY	846B		A
JOHNSON & JOHNSON	533B		BBB
ABBVIE INC.	356B	-	AA	-	-
ROCHE HOLDING AG	324B		AA
ASTRAZENECA PLC	282B		A
NOVARTIS AG	278B		AAA
MERCK & CO., INC.	275B		A
NOVO NORDISK A/S	203B		A
AMGEN INC.	179B		A
GILEAD SCIENCES, INC.	163B		AA
PFIZER INC.	146B		A
BRISTOL-MYERS SQUIBB COMPANY	115B		A
VERTEX PHARMACEUTICALS INCORPORATED	109B		AA
SANOFI	103B		AA
GSK PLC	100B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	83.01B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	52.58B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	51.53B		AA
BAYER AG	42.76B		AA
Average	212.98B		AA
Weighted average by Cap.			AA